Results 1 to 10 of about 29,027 (201)

Multi-epitope vaccine design against human metapneumovirus via reverse vaccinology and molecular modelling. [PDF]

Sci Rep
Bukhari K.
europepmc   +1 more source

Global Burden of Human Metapneumovirus: Bridging Gaps in Prevention, Diagnostics and Treatment. [PDF]

Public Health Chall
Adepoju VA, Adnani QES, Jamil S, Mohammadnezhad M, Abdulrahim A.   +4 more
europepmc   +1 more source

Human metapneumovirus: an emerging public health threat and harbinger of a new pandemic. [PDF]

GMS Hyg Infect Control
Saraç İA, Uzun SU.
europepmc   +1 more source

Mixed Infectious-Immune Pneumonitis Associated with PD-L1 Blockade: A Case of Durvalumab-Induced Lung Injury Complicated by Human Metapneumovirus Infection. [PDF]

J Clin Med
Pipitò L, Mazzola CV, Giacchino I, De Rosa R, Gagliardo CM, Lipari AG, Monte P, Furia F, Mannino E, Pecoraro R, Scichilone N, Cascio A.   +11 more
europepmc   +1 more source

Repurposing Metal-Based Therapeutics for Human Metapneumovirus (HMPV): An Integrative Computational Approach. [PDF]

Bioinorg Chem Appl
Dubey A, Kumar M, Tufail A, Dwivedi VD, Ragusa A.   +4 more
europepmc   +1 more source

Human metapneumovirus in children with acute lower respiratory infections: effects on clinical and disease severity. [PDF]

BMC Pediatr
Yang S, Lu S, Guo Y, Liu J, Wang L.
europepmc   +1 more source

Immunoinformatic design of chimeric multiepitope vaccine for the prevention of human metapneumovirus (hMPV). [PDF]

BMC Infect Dis
Ehsasatvatan M, Kohnehrouz BB, Salavatizadeh M.   +2 more
europepmc   +1 more source

Epidemiology of Human Metapneumovirus Infection in a Community Setting, Seattle, Washington, USA. [PDF]

J Infect Dis
Elias-Warren A, Bennett JC, Iwu CD, Starita LM, Stone J, Capodanno B, Prentice R, Han PD, Acker Z, Grindstaff SB, Reinhart D, Logue JK, Wolf CR, Boeckh M, Kong K, Xie H, Kim G, Greninger AL, Perofsky AC, Viboud C, Uyeki TM, Englund JA, Roychoudhury P, Chu HY.   +23 more
europepmc   +1 more source